Page last updated: 2024-10-30

mebendazole and Premature Birth

mebendazole has been researched along with Premature Birth in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).

Research Excerpts

ExcerptRelevanceReference
"664) was found between the mebendazole group and the placebo group in terms of numbers of miscarriages, malformations, stillbirths, early neonatal deaths and premature babies (28 versus 31, respectively)."5.12Lack of risk of adverse birth outcomes after deworming in pregnant women. ( Casapia, M; Gotuzzo, E; Gyorkos, TW; Larocque, R, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gyorkos, TW1
Larocque, R1
Casapia, M1
Gotuzzo, E1

Trials

1 trial available for mebendazole and Premature Birth

ArticleYear
Lack of risk of adverse birth outcomes after deworming in pregnant women.
    The Pediatric infectious disease journal, 2006, Volume: 25, Issue:9

    Topics: Animals; Antinematodal Agents; Birth Weight; Double-Blind Method; Endemic Diseases; Female; Hookworm

2006